Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer.

已完结 10 由 Aixuexi 发布于 2026/9/17 13:56:00

DOI:10.1007/s10549-025-07694-7
作者：Ezgi Turkoglu,?Goncagul Akdag Topal,?Sedat Yildirim,?Oguzcan Kinikoglu,?Nisanur Sariyar Busery,?Miray Aydogan,?Hacer Sahika Yildiz,?Seval Orman,?Ayberk Bayramgil,?Tugce Kubra Gunes,?Mustafa Alperen Tu
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：Background: Dual HER2 blockade with trastuzumab and pertuzumab combined with neoadjuvant chemotherapy improves outcomes in HER2-positive breast cancer. The optimal taxane backbone (paclitaxe

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyCommunication Distance Estimation for Power Line Communication Using Various Differently Constituted Power Cables